From their 35th birthday, everyone with German statutory health insurance is entitled to a health check every three years. Known as the "Check-up 35" (officially the Gesundheitsuntersuchung), it is regulated in detail: what the family doctor asks, measures and sends to the lab is set by a directive of the Federal Joint Committee (G-BA), the body that decides what statutory health insurance (GKV) pays for. Here is what it contains, what it leaves out, how it fits the evidence, and why its future is now under review.
Who is eligible
Between their 18th and 35th birthdays, insured adults may have the check-up once; from 35 onwards, every three years. After a check-up, no further one is due in the following two calendar years. It costs you nothing.
What is included
- History: personal, family and social history, aimed at a risk profile, including cancers in the family. Where medically indicated, cardiovascular risk should be estimated with a risk chart; which one is not specified.
- Physical examination ("full status"): including heart, lungs, neck arteries, abdomen, foot pulses, skin, musculoskeletal and nervous system, height, weight and blood pressure.
- Vaccination status check, with advice to catch up on missing vaccines.
- Blood (routinely from 35; between 18 and 34 only with a risk profile such as obesity, high blood pressure or a relevant family history): a lipid profile of total, LDL and HDL cholesterol and triglycerides, plus fasting glucose.
- Urine dipstick (from 35 only): protein, glucose, red and white blood cells, nitrite.
- One-time screening for hepatitis B and C from 35: a test for hepatitis B surface antigen and for hepatitis C antibodies. If either is positive, the same sample is tested for viral genetic material. People vaccinated against hepatitis B do not need the B test.
- Counselling: results, motivational counselling on smoking, exercise and diet, a pointer to cancer screening and, where useful, a written prevention recommendation.
What is not included
Neither the directive nor the information sheet of the National Association of Statutory Health Insurance Physicians (KBV) provides for ApoB or lipoprotein(a), HbA1c (long-term blood sugar), creatinine and eGFR (estimated kidney function), the urine albumin-to-creatinine ratio (a sensitive marker of kidney damage; the dipstick only picks up larger amounts of protein), an ECG, ultrasound, thyroid tests or a blood count. The check-up is a population-wide net, not a personal work-up.
What the evidence says
The best evidence on general health checks is sobering. A Cochrane review pooled 17 randomised trials, 15 of which reported outcomes for 251,891 adults. General checks did not change total mortality (risk ratio 1.00; 95% confidence interval 0.97–1.03), cancer mortality (1.01) or cardiovascular mortality (1.05). The authors concluded that general health checks are unlikely to be beneficial. See The annual physical is dead and Why Cochrane says standard check-ups don't work.
That does not make the German check-up worthless. Its core parts (blood pressure, lipids, glucose, smoking, vaccination) target risks that are easy to treat. The value appears only when an abnormal result leads to action, and a single surgery reading is often not enough; see Blood pressure: the most important number you can measure at home.
The hepatitis test has its own rationale: chronic hepatitis B and C often cause no symptoms for years and can lead to cirrhosis, liver cancer and, in the worst case, liver transplantation; early antiviral treatment can prevent this.
The US Preventive Services Task Force (USPSTF, US) advises against a screening ECG in symptom-free low-risk adults and finds the evidence insufficient for higher-risk adults, so its absence is reasonable.
What you can ask your GP to add
The real line runs not between "in the check-up" and "private extras" but between screening without a reason and investigation with a reason. Under German social law (§ 27 SGB V), insured people are entitled to care needed to detect a disease, so tests with a medical reason are normal GKV care. Without one, they are an IGeL ("individual health service"), which you pay yourself, under a written contract and billed according to the official fee schedule for doctors (GOÄ).
With a reason: covered by GKV
Creatinine/eGFR and urine albumin in diabetes, high blood pressure or cardiovascular disease; the international kidney guideline KDIGO 2024 recommends both tests in at-risk groups (more). HbA1c with a borderline fasting glucose. ApoB with high triglycerides, diabetes or obesity, where it reflects risk better than LDL. Lipoprotein(a) with early heart disease in the family. An ECG for symptoms.
Without a reason: usually IGeL
ApoB and Lp(a) "just to be safe": the European societies ESC and EAS recommend ApoB for risk assessment and advise measuring Lp(a) once in a lifetime (more), but neither is part of the check-up. Before paying for any test, ask what a result would change.
The check-up within German screening
Cancer screening is governed by separate directives. The statutory offer as of October 2026:
- From 18: one check-up up to 34; from 35 every three years, plus hepatitis B and C once.
- Women from 20: annual genital examination; ages 20–34 an annual cervical smear (Pap test), from 35 a combined smear and HPV test every three years.
- Women from 30: additionally, an annual breast examination by hand.
- From 35: skin cancer screening every two years (dermatoscopy).
- Men from 45: annual examination of prostate and external genitals by touch.
- From 50: bowel cancer screening for women and men: a stool test every two years or colonoscopy, with at most two screening colonoscopies (colonoscopy).
- Women 50–75: the mammography screening programme every two years; extension to 45–49 decided, expected from August 2027.
- Ages 50–75: annual low-dose lung CT for heavy current and former smokers meeting set criteria (since April 2026).
- Men from 65: a one-time ultrasound for abdominal aortic aneurysm.
The check-up under review
German law (§ 25 SGB V) now requires the G-BA to review the check-up against current evidence and decide on changes by 31 December 2027. On 15 October 2026 the G-BA opened that review: age limits, target groups, frequency, content, differences between the sexes and target diseases, with a possible focus on cardiovascular disease. It has asked the independent institute IQWiG to assess a risk-adapted check-up, the urine dipstick and a one-time HIV test. The outcome is open.
What this means for you
- Use the appointment, but as a conversation about your risks, not a full service.
- Bring: your vaccination record, a list of medications, home blood pressure readings and your family history (early heart attacks or strokes, cancer, kidney disease).
- Ask: "What is my cardiovascular risk over the next ten years?" "Do I have a reason for kidney tests or Lp(a)?" "Which cancer screening am I due for now?"
- When offered paid extras: take time to decide, and ask how an abnormal result would change your care.
Bottom line
The Check-up 35 is a lean, population-wide baseline: blood pressure, lipids, fasting glucose, urine dipstick, vaccination status and, once, hepatitis B and C. In trials, general health checks do not lower mortality; the appointment becomes useful when it finds treatable risks and you ask what else is medically justified for your profile. With risk factors, kidney tests including urine albumin and a one-time Lp(a) are well founded; an ECG or ultrasound without symptoms is not.
Evidence: ★★★ High (no mortality benefit from general health checks) · ★★ Moderate (targeted additional tests for people with risk factors).
References
- Gemeinsamer Bundesausschuss (G-BA). Richtlinie über die Gesundheitsuntersuchungen zur Früherkennung von Krankheiten (Gesundheitsuntersuchungs-Richtlinie). Fassung vom 19.12.2019, zuletzt geändert am 20.11.2020, in Kraft seit 12.02.2021.
- Kassenärztliche Bundesvereinigung (KBV). PraxisInfo Gesundheitsuntersuchung (Check-up). Stand: September 2021.
- Gemeinsamer Bundesausschuss (G-BA). Screening auf Hepatitis B und C neuer Bestandteil des Gesundheits-Check-ups. Pressemitteilung, 20. November 2020.
- Gemeinsamer Bundesausschuss (G-BA). Hautkrebs-Screening und Check-up: G-BA berät über das aktuelle Früherkennungsangebot. Meldung, 15. Oktober 2026; Beschluss zur Einleitung des Beratungsverfahrens „Überprüfung der allgemeinen Gesundheitsuntersuchung“, 15. Oktober 2026.
- Gemeinsamer Bundesausschuss (G-BA). Krebsfrüherkennungs-Richtlinie (KFE-RL), in Kraft seit 12.03.2026; Richtlinie für organisierte Krebsfrüherkennungsprogramme (oKFE-RL), in Kraft seit 02.10.2026.
- Gemeinsamer Bundesausschuss (G-BA). Mammographie-Screening künftig auch für Frauen von 45 bis 49 Jahren. Pressemitteilung, 15. Oktober 2026.
- Krogsbøll LT, Jørgensen KJ, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev. 2019;(1):CD009009. doi:10.1002/14651858.CD009009.pub3. Open article (DOI) ↗
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117-S314. Find on PubMed ↗
- Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188. Find on PubMed ↗
- US Preventive Services Task Force. Cardiovascular disease risk: screening with electrocardiography. Final recommendation statement. 12 June 2018.
This article is general information and not individual medical advice. Decisions about tests and treatment belong in a conversation with your own physician.